Injectable healing protocol: 23 mg daily (upper end of range), systemic injection - not into the wound itself - daily until the wound resolves, plus 12 weeks maintenance Topical healing protocol: 2 %4 % in a wound-appropriate vehicle applied 23 times daily to wound margins (never into an open, actively bleeding wound) under clinician supervision Stacking: GHK-Cu pairs exceptionally well with BPC-157 and TB-500 - the so-called GLOW stack - for complex healing cases
Only after the new drug has been subject to many years of testing on volunteer patients, and a comprehensive investigation into any side-effects and any other possible complications has taken place will the evidence be placed before the MHRA
Ongoing studies explore its influence on cellular communication pathways associated with nutrient utilization, energy balance, and metabolic adaptation
This 10 mL B12 research solution is designed for laboratory studies exploring cobalamin behavior, stability, and assay development in model systems
The route of administration is intravenous
